Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported ...

Artificial intelligence's consistent validation reflects algorithmic design, not objective assessment. Learn cognitive ...

If vulnerable nations no longer receive U.S. assistance that helps them meet economic objectives and fosters democratic development of their societies ...

A recent survey from The Queen’s Reading Room, the charity and book club of Queen Camilla, and other surveys, have found that ...

Kaerus Bioscience has received US Food and Drug Administration’s (FDA) designations for KER-0193 to treat Fragile X syndrome ...

This rumor circulated in May 2025 amid news of Qatar offering the U.S. Department of Defense a $400 million luxury Boeing 747 ...

Depression is among the most widespread mental health disorders worldwide, typically characterized by persistent feelings of sadness, a lack of interest in daily activities and dysregulated sleep ...

Non-pharmacological interventions, such as mindfulness and exercise, may improve sleep for MS patients, a meta-analysis of studies found.

Alpha Cognition Inc. ("Alpha Cognition", or the "Company") today announced its financial results for the first quarter ended March 31, 2025. "We closed the quarter on a strong note, launching ZUNVEYL® ...

In a world designed to distract you, the ability to focus has become an increasingly valuable skill. However, this doesn’t ...

Eduardo Duarte is a dynamic entrepreneur specializing in music technology, based in Guimarães, Portugal. With a diverse ...

Loneliness has become such a widespread problem that Silicon Valley billionaires are now highlighting it to market AI ...